As we show here, CQ and HCQ can be promising drugs for neurofibroma to decrease the collagen component, which is overexpressed in cutaneous and non-cutaneous lesions, through an increase in MMP1. The gene discussed is MMP1; the disease is plexiform neurofibroma.